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Abstract
Retinitis pigmentosa (RP) is a group of inherited degenerative eye diseases char-
acterized by mutations in the genetic structure of the photoreceptors that leads to
the premature death of both rod and cone photoreceptors. Defects in particular
genes encoding proteins that are involved in either the photoreceptor structure,
phototransduction cascades, or visual cycle are expressed in the rods but ultimately
affect both types of cells. RP is “typically” manifested by a steady death of rods
followed by a period of stability in which cones survive initially and then inevitably
die too. In some RP cases, rods and cones die off simultaneously or even cone death
precedes rod death (reverse RP). The mechanisms and factors involved in the de-
velopment of the different types of RP are not well understood nor have researchers
been able to provide more than a limited number of short-term therapies. In this
work we trace the progression of RP to complete blindness through each subtype via
bifurcation theory. We show that the evolution of RP from one stage to another of-
ten requires the failure of multiple components. Our results indicate that a delicate
balance between the availability of nutrients and the rates of shedding and renewal
of photoreceptors is needed at every stage of RP to halt its progression. This work
provides a framework for future physiological investigations potentially leading to
long-term targeted multi-facet interventions and therapies dependent on the partic-
ular stage and subtype of RP under consideration. The results of this mathematical
model may also give insight into the progression of many other degenerative eye dis-
eases involving genetic mutations or secondary photoreceptor death and potential
ways to circumvent these diseases.
keywords: retinal degeneration, rod-cone RP, reverse RP, bifurcation set,
RdCVF
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Introduction
Background of Retinitis Pigmentosa
Retinitis Pigmentosa (RP) is a heterogeneous group of inherited disorders that affects
approximately 1 in 4000 individuals (nearly 1.5 million) worldwide [1, 2, 3]. This group
of disorders is often classified as primary or syndromic RP. In the case of syndromic RP,
which account for about 20-30% of all cases, the patients have an associated non-ocular
disease with RP with abnormalities in one or more organs [4, 2]. In contrast, primary
RP involves only the eye. RP is primarily genetically programmed with more than 45
genes associated with this disease identified to date. These genes account for only about
60% of all cases. RP may be inherited from one or both parents (autosomal-recessive RP,
autosomal-dominant, or X-linked RP, which account for approximately 20-30%, 15-20%,
and 6-10% of the cases, respectively) or may be caused by a new mutation even though
there may be no family history of the disease [4, 2, 5, 6, 1, 7]. Less common modes of
inherited RP include digenic and mitochondrial [2].
RP has been associated with mutations or errant genes encoding for proteins that
are essential for rod survival and certain genetic products that are damaging to the rods
[2, 4, 7, 8, 9]. Even though mutations are normally only expressed in the rods their effects
ultimately cascade to the cones. People usually are diagnosed only when they experience
serious vision problems making it difficult to decipher the mechanism of development and
the channels by which RP develops. Adding to this challenge is the variability of its
progression and its time of onset within each individual [8, 10, 11]. The sequences of
events (i.e., clinical manifestations) of the various sub-types of RP are well-documented
[2, 12, 11] but this sequential progression varies from individual to individual.
RP is often classified into various sub-types depending on the location of the vision
field that is affected. The most common clinical manifestation is rod-cone RP and is char-
acterized by difficulty seeing at night, followed by night blindness (nyctalopia), narrowing
of the mid-peripheral field of vision (where the rods are more prevalent), and ultimately
a loss of central vision[9, 4, 3]. Night blindness is the hallmark of rod-cone RP but given
that rod function is primarily affected, this is of no surprise since rods contribute solely to
night vision. Even though rod-cone RP has a better overall prognosis and slower progres-
sion in comparison with other sub-types of RP, the range of the onset of clinical rod-cone
RP to its noticeable changes observed by the patient can vary widely in all cases. In this
most common form of RP, the causal mutations affect genes exclusively expressed in the
rod cells in an overwhelming number of cases and rod death far exceeds and precedes
cone death [2]. Less common forms of RP see an equal loss of rods and cones or even a
cone death exceeding rod death (cone-rod RP or reverse RP) [4, 2]. Cone-rod dystrophy
(reverse RP) is associated with a cone loss preceding rod loss and as a consequence reduc-
tion of the central vision, acuity, and color vision are manifested early in the progression
of the disease, followed by reduction of the mid-peripheral visual field and night blindness
at later stages. However, unlike the rod-cone RP where patients’ color vision remains
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good until the central vision is affected at levels of 20/40 or worse, patients with cone-rod
RP experience deterioration of their color vision, ability to adapt to light and day vision
very early in the disease as well as the loss of normal cone functioning, which leads to
photophobia.
Interactions of Photoreceptors
Research that might shed light on improving the photoreceptors longevity has been
paramount to physiological, anatomical, and medical research in the last 2 decades due to
the prominent role that these cells play in the vision process [13]. The photoreceptors are
the rods and cones, located in the retina, that convert light energy into nerve impulses
through the process of visual transduction[14]. The rods and cones are specialized for dif-
ferent aspects of vision: the rods and cones are different in shape (cylindrical vs. conical),
contain different types of photopigment, and are distributed differently throughout the
retina[15]. The reduction of normal light vision, visual acuity, detail perception, night vi-
sion, and narrowing of the peripheral fields can be caused by a depletion of cones and rods,
respectively [3]. The photoreceptors undergo tremendous oxidative stress over the course
of a day and undergo a continuous cellular renewal and periodic shedding process of their
outer segments (OS) in order to minimize depletion and help ensure proper functioning of
these cells [15, 16, 17, 18]. Photoreceptors shed approximately the same amount of mate-
rial that is renewed over the course of a day so that the length roughly remains constant,
with complete renewal in rods and cones occurring from 11 days up to 3 weeks depending
on the photoreceptor and its location within the retina [15, 19, 20, 21, 22, 23, 24, 25, 26].
The shedding and renewal of photoreceptors, their interactions, and circadian rhythms
were previously examined and discussed in greater detail [27, 28].
Much research has examined the processes of renewal and shedding within the pho-
toreceptors and suggests the photoreceptors together with the adjacent retinal pigment
epithelium (RPE) operate as a functional unit [20, 29, 30, 19, 31, 32, 33, 18, 34, 23, 22, 35,
36, 21, 37, 38]. The rod and cone cells undergo a daily rhythmic shedding in which their
photoreceptor outer segments (POS) are phagocytized by the RPE. The RPE recycles
parts of the shed POS for future use by the photoreceptors and contributes additional
trophic and growth factors utilized in the renewal process of these cells [29, 3, 39, 36]. The
RPE transports, secretes, and redelivers essential growth factors such as PEDF, CNTF,
bFGF, Gas6, PDGF, and ATP, metabolites (including glucose, retinal, and omega-3 fatty
acids), ions, and water to and from the photoreceptors [38, 40, 41, 42, 37, 43, 44]. It is
unclear if other essential proteins are linked to the interactions of these two retinal tissues
but the interdependency of the RPE and photoreceptors is key to the proper functionality
of the eye.
Pivotal to the vision is also the connection and interplay between the rods and cones.
These cells have long been suspected of communicating directly or indirectly with each
other [39]. It has been recently shown that the rods produce a protein referred to as
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the Rod-derived Cone Viability Factor (RdCVF) that is essential for the functionality
and survival of the cones [45, 3, 46, 47, 48, 49]. While the neural degeneration of the
photoreceptors that typically results from genetic defects and mutations (such as RP)
may disrupt and break the balanced shedding and renewal processes leading to shorter OS
and, in some cases, the complete disappearance of the rods and cones [3, 50], the amount
of RdCVF appeared to be the same in both normal and mutated rods prior to their
degeneration. Additionally, a subsequent decrease in RdCVF was reported to be strongly
correlated with the decrease in the number of rods during their degenerative process [46].
The effect of RdCVF appears to be independent of the casual mutation leading to rod
degeneration [45, 46, 48]. Experiments have revealed that RdCVF had a significant cone
rescuing effect, that its protective effects did not extend to degenerating rods, and that
the presence of the rod cells is not necessary for cone survival as long as RdCVF is present
[48, 45, 46, 47, 49, 28]. Moreover, RdCVF was also shown to significantly preserve cone
function, a very promising discovery since maintaining functional cones even when 95% of
the cones are gone may prevent blindness [48]. The discovery that rods produce RdCVF,
which is essential for cone functionality and viability, and that their death deprives the
cones from this element and triggers their degeneration has far-reaching implications. It
is yet unclear whether the RPE plays any role in the transport of this protein but it is
clear that RdCVF provides an essential direct help from the rods to the cones without
negatively affecting the rods.
Hypotheses of Photoreceptor Degeneration and Death in RP
It is crucial to identify the precise cause(s) of both rod and cone cell death, as it is
the secondary wave of photoreceptor death in RP patients that results in total blindness
[29, 51]. Substantial experimental research (consisting mainly of animal models) has
been devoted to this effort. There are several hypotheses/theories as to what leads to
photoreceptor death in RP, but none of them have been definitively proven [29]. All
theories suggest indirectly or directly that mutations result in gene products that are
damaging to photoreceptors (including their signaling pathways and cell-cell interactions)
or that mutations cause lack of a protein that is needed for photoreceptor survival [8].
Among these theories is one which led to the development of antioxidant therapy for cone
survival and is based on the hypothesis that the death of rods leads to higher oxidative
stress in the retina, which eventually kills the cones [29]. This was demonstrated by
showing that antioxidants promote cone survival and vision in rd1 mice as they get older.
Another theory comes from the idea that the rods produce some kind of signal that is
essential for maintaining cone viability, so that the disappearance of rods for whatever
reason would deprive the cones of this signal and trigger their degeneration [3]. This theory
was supported through various experiments on mice and rats and led to the discovery of
the RdCVF. A third theory comes from the synergistic interactions of the RPE and the
photoreceptors since defects in genes normally expressed in the photoreceptors can lead
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to degeneration of the RPE and vice versa [38]. The inability of the RPE to secrete
neuroprotective and growth factors such as PEDF, bFGF, and CNTF that can protect
photoreceptors from damage has been implicated in the pathogenesis of retinal diseases
([38] and references therein). Inappropriate signaling between photoreceptors and bipolar
cells whose signaling pathway remains intact for RP patients has also been postulated
as a potential reason for the secondary death wave of photoreceptor in rod-cone RP
patients [52]. Toxicity released by mutated and degenerate rods is another hypothesis
but this theory has been challenged by experiments which showed that cone death is
uniform in space irrespective of where they are in relationship to the mutated rods [53, 3].
Another related hypothesis is that microglia activated by ongoing rod death migrate to
the photoreceptor layer and secrete toxic substances that kill cones [54].
Depletion of photoreceptors or abnormally short OS that result in oxygen toxicity only
explain part of the cause of cell death in RP [55, 13]. Although rods die by apoptosis, which
generally avoids release of potentially toxic cellular metabolites and prevents extension of
cellular breakdown to surrounding regions of tissues, it seems possible that degeneration
of the abundant rods (numbering about 90-120 million in the human eye) could have
adverse effects upon the adjacent cones and nearby bipolar cells [3]. Even though there
are some modifications in the inner retinal neurons these nearby neurons do not undergo
a widespread death following the first wave of photoreceptors death, as one would expect.
The main flaw in these toxicity theories is that cone cell death occurs very slowly and
continues long after all rods have died. While toxicity might explain photoreceptors
degeneration in the short term (at the early stage of the disease) it fails to hold in the
long run [3].
The theory of oxidative stress fails to completely explain the sequential photoreceptor
death in reverse RP (or in cases when both cones and rods die simultaneously) and in
the rod-cone RP cases it raises the questions as to why rods die preferentially and why
only cones are saved when treated with antioxidants. In an attempt to address this
researchers have postulated that rods might be more sensitive to reactive oxygen species
(ROS) and thus they die first, which then probably further increases the oxidative stress
in the retina. The generation of ROS, by proteins in various retinal layers, is part of
the normal maintenance of the retina [29]. Rods are more numerous than cones and are
metabolically active cells with a high level of oxygen consumption. Choroidal vessels are
not subject to autoregulation by tissue oxygen levels and as death of rods occurs, the
tissue level of oxygen in the retina increases [56, 57]. Oxygen levels in the outer retina
vary inversely with oxygen consumption; as the number of rods in a particular area of the
retina decreases, oxygen consumption decreases, and thus oxygen levels increase. Based
on this, one would expect regions of human retinas with the highest rod/cone ratio (the
far periphery of the eye) to be the first regions to experience photoreceptor death due to
their exposure to dangerously high levels of oxygen [8]. This is what we see in the case
of rod-cone RP where the peripheral visual field is constricted first but not in the case
of reverse RP. While this theory might not depict the entire picture it provides one of
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potentially multiple causes of cell death in RP as it has been established experimentally
that high tissue levels of oxygen are damaging to photoreceptors and result in cell death
[58, 59].
Another valuable insight for the death of rods and cones in RP comes from our current
understanding of the RPE as a vital component of the visual system that supports normal
photoreceptor function. Integrated interactions between photoreceptors and the RPE are
key in the visual process. Among these interactions are the visual cycle (in which the
structure of retinal is changed by light transduction: in photoreceptors from 11-cis- to
all- trans-retinal and in the RPE from all-trans- to 11-cis-retinal) and the phagocytosis of
photoreceptor OS (which contributes to the photoreceptors shedding process and the op-
timal photoreceptor structure necessary for light perception). Experiments have revealed
that signs of photoreceptor apoptosis due to intensified light exposure were fully reversible
potentially due to increased secretion and synthesis of different neuro protective factors
by the RPE such as PEDF, CNTF, and bFGF, which are known to be protective against
light damage [38]. Among the essential proteins linking the RPE and photoreceptors is
the interphotoreceptor retinoid binding protein (IRBP) which is primarily a product of
the rods, with less of a contribution from the cones [60, 61, 62, 3]. A decrease in IRBP
due to the death of rods as well as a loss of the RPE-recycled products of rod OS shed-
ding may contribute to the observed cone OS shortening and ultimately, the cone cell
death found in RP retinas. This is mainly attributed to an associated local deficiency in
vitamin A, as it is known that vitamin A deficiency causes photoreceptor OS shortening
and cell death [63, 64]. The inability of the RPE to provide essential neuro protective
and growth factors to individuals with RP opens a realm of possibilities that call for a
thorough investigation of the interactions of photoreceptors and their exchange of trophic
factors.
Another protein that seems to be key in the interactions of the photoreceptors respon-
sible for the viability of the cones is the RdCVF. RdCVF is a truncated thioredoxin-like
protein specifically expressed by the rods. Experiments demonstrated a 40% rescue ef-
fect in cones and thus slowed down the degeneration of cones in chick and mouse models
[45, 46]. Additional experiments revealed that RdCVF had a bigger effect in the function-
ality of cones than in their viability [46]. Although RdCVF is a good candidate to target
for cone survival in RP, a number of issues remain to be addressed. For example, the
mechanism of action underlying the cone survival effect needs to be better understood as
well as the intracellular signaling pathways that are involved [48]. Another issue that is
currently being researched is the delivery mechanism of RdCVF as injection of a protein
but this might not to be a satisfactory option for the long term. Gene-based delivery
through viral vectors or using encapsulated cell technology would ensure a more stable
and persistent release of RdCVF [48]. Irrespective of the mutation, the final common
pathway of the first wave of photoreceptor death is degeneration through apoptosis; the
mechanism underlying secondary wave of cone (in rod-cone RP) or rod (reverse RP) death
remains unknown [3].
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Mathematical Model
In an attempt to shed light into the underlying mechanisms and factors involved in the
development of the different types of RP we create a mathematical model of photoreceptor
interactions that explicitly incorporates RdCVF and implicitly includes other essential
photoreceptor neuroprotective and growth factors secreted by the RPE. We consider two
different classes of rod cells, mutated and normal, to represent those that have had their
functionality affected by the genetic mutation(s) and those that have not[28, 65, 66] (see
Figure 1 for a simple physiological illustration). This distinction between the two classes
of rods is essential due to the numerous genes and processes affected by the mutations
associated with RP[12, 2, 8] and the great variability of the disease[67]. While much
RP research has characterized the different types of mutations that cause RP, we are
not modeling and do not address how the mutation occurred or what type of mutation
it is or what it affects. Rather, our model focuses on the interaction and structure of
the photoreceptors and their OS in relation to the renewal and shedding process. We
simply assume that there is a mutation that has already been expressed and therefore
some of the rods cells can be thought of as “mutated rods” [67]. We similarly do not
model the visual transduction or retinal metabolism[14]. Thus our model can be thought
of as representative of the photoreceptor and RPE interactions at or after the onset of
RP[28]. As is often done, we used previous mathematical models of the eye together with
experimental evidence to assume that both eyes are identical and thus consider only one
eye [65, 28, 68, 2]. This work builds on our previous mathematical model of photoreceptor
interactions in a healthy eye but now we incorporate mutated rods that are present in RP.
For the sake of mathematical simplicity, we also ignore any spatial effects, for example, the
different spatial distribution of the photoreceptors at various locations in the retina [66].
Two other mechanistic models of RP focus on the kinetics of neuron degeneration and
lateral inhibition of nearby cells and not on cone and rod photoreceptor interaction[66, 69].
In order to focus on the mechanisms behind the various manifestations of RP, we
create a mathematical model that includes two different classes of rod cells, Rm and Rn
(corresponding to mutated and normal rod OS, respectively), one type of cone OS (green,
red, blue cone OS are grouped together), C, and a trophic pool (representative of the
RPE’s neuroprotective and growth factors) from which the rods and cones draw their
nutrients, T . We utilize the framework from epidemiology and population dynamics to
model the interactions between the photoreceptors and trophic factors as a predator-prey
system; see Figure 1. Even though no new rods or cones are created in a mature retina,
the process of shedding and renewal lends itself to the interpretation of birth and death of
the rods and cones and we incorporate this interpretation into our model [32, 70, 33]. We
view our units as “cells” and therefore fractions of a cell are the POS in these three types of
photoreceptors. Experiments have shown that in a rod-free retina the absence of cone OS
corresponds to blindness even though the living cone cell remains[71, 26]. We will take this
same perspective. Similarly the nutrients represent fractions of the trophic pool consisting
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of growth factors, metabolites, ions, and water (e.g., PEDF, CNTF, bFGF, Gas6, PDGF,
ATP, glucose, retinal, and omega-3 fatty acids) to and from the photoreceptors provided
or secreted by the RPE [38, 40, 41, 42, 37, 43, 44]. In RP, degeneration can also extend
to the outer retina nuclear layers and the ganglion cell layer but we focus this work only
on the photoreceptor cells [71, 72]. Our model extends the healthy eye model of [28]:
R˙n = Rn(anT − µn −m)
R˙m = Rm(amT − µm) +mRn
C˙ = C(acT − µc + dnRn + dmRm)
T˙ = T (Γ− kT − βnRn − βmRm − γC), (1)
where all parameters are nonnegative; see Table 2 for definitions of the parameters. We do
not distinguish between the various factors that constitute the trophic factors so as to focus
on the critical interactions of the rods and the cones[28]. Furthermore, this allows our work
to stay consistent with all experiments in the literature where no distinction between a rod-
trophic and a cone-trophic pool is made [45, 29]. Our model assumes that both the rods
and the cones take more nutrients from the trophic pool than they contribute (as recycled
products) and that they convert these trophic factors to new OS discs at some ratio. To
the best of our knowledge, no experimental work has been done to date that discusses
the production rate of trophic factors in the absence of photoreceptors; this current work
supposes that the production of the trophic factors is logistic in nature and thus will reach
an equilibrium (governed by Γ and k) in the absence of photoreceptors, instead of growing
without bound[28]. The structure of this mathematical model incorporates the presence,
through the parameters dm and dn, of the RdCVF protein that helps cone survivability
and functionality yet does not negatively influence the rod population [45, 3, 8, 48].
Experimental evidence suggests that the RdCVF directly affects the cones and thus we
model this as a direct rod-cone interaction, the necessity of which was already established
in [28]. The literature does not suggest that mutated rods stop or decrease production of
RdCVF and thus our model includes this possible contribution of RdCVF by the mutated
rods via dm. This model reduces to the previous work in [28] if we ignore the terms related
to the mutated rods, i.e., m = Rm = dm − βm = 0, and do not consider saturation of the
trophic pool, k = 0.
We define the following terms:
Dm =
µm
am
, Dn =
µn +m
an
, Dc =
µc
ac
, DT =
Γ
k
, (2)
which are key in our analysis. Based on the equations (1), we determine steady state
solutions (Rn, Rm, C, T ) that correspond to the various physiological stages of RP and
whose corresponding stage and subtype of RP is summarized in Table 3. Our system
yields seven equilibria given by
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E1 : (0, 0, 0, 0),
E2 : (0, 0, 0, DT ),
E3 :
(
0,
B1
amβm
, 0, Dm
)
,
E4 :
(
0, 0,
B2
acγ
,Dc
)
,
E5 :
(
0,
B3
amdm
, C∗
5
, Dm
)
, where C∗
5
=
dmB1 − βmB3
γamdm
E6 : (R
∗
n6, R
∗
m6, 0, Dn) , where
R∗n6 =
A1A3
an(mβman + βnA1)
, R∗m6 =
mA3
mβman + βnA1
,
E7 : (R
∗
n7, R
∗
m7, C
∗
7
, Dn) , where
R∗n7 =
A1A2
an(dnA1 + dmanm)
, R∗m7 =
mA2
dnA1 + dmanm
,
and C∗
7
=
1
γan
[
A3 − A2
(
mβman + βnA1
dnA1 + dmanm
)]
, (3)
with
A1 = anam (Dm −Dn), A2 = anac (Dc −Dn),
A3 = ank (DT −Dn), B1 = amk (DT −Dm),
B2 = ack (DT −Dc), B3 = amac (Dc −Dm).
The ratios defined by the Di for i = m,n, c, T represent key quantities that govern the
progression of RP and will be discussed in Appendix 1.
Progression of RP through Equilibrium Solutions
Analysis of the seven steady state solutions (3) give conditions on the parameters for the
linear stability of the various stages of RP [39]. Once a particular stage of RP has been
reached, these conditions represent quantities that must persist in an individual to prevent
further progression of RP (e.g., moving to a more advanced stage of RP) and equivalently
they give the parameters involved if RP progression continues. These conditions involve
the terms in (2): Dm, Dn, Dc, and DT , which turn out to be the key quantities predicted
by our model to govern the progression of RP.1 The first three of these terms are the ratios
of the OS departure (due to shedding and/or mutation) to the renewal for a given class
1A non-dimensionalization of the original system, while reducing the parameters from 14 to 10 yields
the same 4 essential ratios in (2) that are involved in the various bifurcation sequences, without additional
insight gained to date with the non-dimensional system. Thus, in order to keep the problem tied to the
physiology as much as possible, we leave our system in its original dimensional form and focus on the
relationship between the Di as the mechanisms governing the progression of RP.
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of photoreceptors. The fourth term, DT , is the ratio of the natural growth rate to the
carrying capacity of the trophic factors in the absence of any photoreceptors (complete
blindness). Our results are supported by previous experimental research suggesting that
disturbances or imbalances of disc shedding to disc formation is associated with RP [73].
Linear stability analysis of the steady state solutions Ei, i = 1, · · · , 7 allow us to de-
scribe the progression of RP for various subtypes within rod-cone RP and reverse RP.
Result: We have observed the equilibria of system (1) in multiple transcritical bifurcations
yielding the following progressions:
1. E7 → E4 → E2; E7 → E5 → E4 → E2 (rod-cone RP)
2. E7 → E6 → E2; E7 → E6 → E3 → E2 (cone-rod RP)
3. E7 → E5 → E3 → E2 (cone-rod RP or simultaneous photoreceptor death)
4. E7 → E2; (simultaneous photoreceptor death)
In each of 1-4, a given equilibria Ei is stable and loses its stability through a transcritical
bifurcation (→) as the subsequent solution becomes stable. The stability of the equilibria
depends on Dm, Dn, Dc, DT .
While not all of the transcritical bifurcations are obvious from inspection, calculations
in a computer software package such as Maple show that at each bifurcation, the two
equilibria become one as they switch (at least) one direction of stability for realistic
parameter values. When Dn = Dm = Dc = DT in parameter space, equilibria E2, · · · , E7
coalesce in an equilibrium point with three zero eigenvalues. We have examined the flow
in the corresponding three-dimensional center manifold of the non-dimensional version
of (1) but have not gained any additional insight regarding the observed bifurcations.
The numerical results on the center manifold flow have confirmed the numerical results
in the original system regarding the stability of only one equilibrium being relevant and
stable at any given point in the realistic range in parameter space. However, we have
observed stable periodic solutions for certain (unrealistic) parameter values. Following
these solutions with MatCont has not yet allowed us to conclude the bifurcation that
gave rise to these limit cycles (one exists in the full 4-dimensional space while the other
exists in the 3-dimensional subspace given by Rn = 0). This aspect of the work is still
ongoing. Thus, while we have analytically observed the sequence of bifurcations in the
above Result for specific realistic parameter values, we are only able to conjecture that
this result holds for all choices of parameter values. The statements below are thus certain
for realistic parameter values and conjectured to hold in general. See Appendix 1 for a
discussion of the analytical results regarding stability of the equilibria, Appendix 2 for
a discussion about parameter estimation of the model, and Appendix 3 for other stable
solutions observed.
10
It is important to observe that E4, for example, represents a state in which both types
of rods have died off and only cones remain; however, the number of cones present in a
given E4 value may differ widely and depends on the parameters. Thus, the bifurcation
E7 → E4 allows for the possibility that the cone levels in E7 have remained the same
as the rods die off (as the values in E7 get closer to those in E4 as the parameters are
varied), but also allows for the possibility that some/many of the cones have also begun
to die off. Thus while we can think of E4 as the typical state in rod-cone RP in which
all rods have died off while the cones remain, we must remember that the level of cones
in E4 may not be the original numbers of cones seen in a healthy eye. Keeping this in
mind, we can interpret the sequences of transcritical bifurcations of the Result as various
subtypes of RP by asking “which photoreceptors remain just after the bifurcation” as we
vary a given parameter or set of parameters.
The sequences given in 1 describe the progression of rod-cone RP via two different
paths. The transitions E7 → E4 → E2 might represent a more aggressive subtype of RP
in which night blindness occurs because of a simultaneous loss of mutated and normal
rods (E7 → E4) before the complete death of cones (E4 → E2). The sequence E7 → E5 →
E4 → E2 might be a less aggressive subtype as the normal rods die off first (E7 → E5)
followed by the mutated rods (E5 → E4) before the cones die off. In both sequences, we
have an intermediate state in which only cones remain before eventually dying off. The
sequences given in 2 describe the progression of cone-rod RP via two different paths, with
the latter having the interpretation of both cone-rod RP and simultaneous death of rods
and cones depending on the actual equilibrium values. The transition E7 → E6 → E2
might represent a more aggressive form in which cones die off before either normal or
mutated rods die off (E7 → E6) and then both types of rods die off together (E6 → E2).
In the path E7 → E6 → E3 → E2, the cones are predicted to die off first (E7 → E6),
then the normal rods (E6 → E3), followed by the death of the mutated rods rendering
complete blindness (E3 → E2). The sequence E7 → E5 → E3 → E2 (in 3) might
represent a somewhat less aggressive form of cone-rod or simultaneous death RP in which
only normal rods die off (E7 → E5) before the cones completely disappear (E5 → E3). In
this sequence the individual will have limited night vision and thus clinically this would
correspond to a cone-rod RP as long as night vision persists to some degree. In these
three sequences (of 2 and 3), it is a type of rod that is the last photoreceptor to die off
thus leading to the classification of all three as cone-rod RP. In contrast, the sequence
given in 4, E7 → E2, describes an additional sub-type of RP in which cones and rods
die off simultaneously. If the functionality of the rods has been extremely affected by
the mutations to the point where night vision has been completely impaired such that
E3 contains no functional rods at all then the sequence E7 → E5 → E3 → E2 can be
considered to be in category 3 where clinically cones and rods are considered to die off
simultaneously. For the manner in which RP is addressed in this work photoreceptors
that contained OS that shed and renew are considered to be functional to some degree.
It is important to again note that some of the above sequences, for example, E7 →
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E4 → E2 may in some situations be clinically classify as the same subtype as E7 →
E2 if the cone levels of the E4 equilibrium are very close to zero and disappear very
shortly after the rods disappear. To the best of our knowledge, no experiments have
made the distinction between normal and mutated rod death during the progression of
any sub-type of RP nor has any research been able to follow the complete progression
of death for a given type of photoreceptor (i.e., produce a time series for the cones or
rods in a given mammalian subject). The results predicted by this model thus provide
a potentially crucial understanding of the progression of RP in terms of the parameters
that give rise to these stage changes. This knowledge gives the framework that will guide
future experiments focusing on potential therapies to slow the inevitable progression of
RP. Insights into what must be considered comes from the stability conditions of the
transcritical bifurcations.
Since the terms Dn, Dm, Dc, DT are all involved in the conditions for the stability
and/or physiological existence of equilibria E2, · · · , E7, future experiments exploring po-
tential long term therapies and interventions would need to keep in mind these quantities
and their interrelatedness as these yield the multi-faceted therapies that can halt RP
brought about by the change in these quantities. By varying between one and three pa-
rameters of the system (1), we can thus observe many different progressions of cone-rod
RP and rod-cone RP (see Figures 2 and 3). Our model suggests examining experimen-
tally the causes of the shedding and renewal imbalances and of changes in the trophic
pool, mathematically seen as changes in Dm, Dn, Dc, and DT , and studying how to alter
these quantities in RP patients [73]. In our system, we have observed exactly one stable
equilibrium Ei, i = 2, · · · , 7 that is stable for a given choice of realistic parameters. This
limits the possibilities for individuals with RP and thus it becomes even more crucial to
have a better understanding of how to clinically control the ratios Dm, Dn, Dc, and DT .
Conclusion
The work presented here offers the first quantitative model of photoreceptor interactions
that can track the progression of RP through all the various stages and subtypes of this
disease and thus offers alternatives to stop its evolution at each stage. Our model predicts
the progression of rod-cone RP (E7 → E4 → E2 and E7 → E5 → E4 → E2) and cone-rod
RP (E7 → E6 → E2, E7 → E6 → E3 → E2, and E7 → E5 → E3 → E2) by examining
the ratios in the quantities Dm, Dn, Dc, and DT . Because the stability of the equilibria
are governed by these ratios, our model suggests that future physiological experiments
and research should focus on the shedding and renewal for each class of photoreceptors
as well as the carrying capacity of the trophic factors as potential leads into long-term
treatments for RP [73].
The stability of the various stages of RP depend on the difference of these ratios,
Di −Dj , for i 6= j and i, j = m,n, c, T given above. The steady state solutions, represen-
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tative of the RP stages, become physiologically relevant through transcritical bifurcations,
when two steady states coincide and then switch their stability[74]. Analytical and nu-
merical evidence indicates that only one of the steady state solutions is stable for realistic
parameter values; for certain unrealistic parameter values, bi-stability has been observed
(see Appendix 3). By varying two parameters, we can track the progression of RP as we
cross the regions in which a given steady state solution representing the current stage of
RP becomes unstable; see Figure 2.
Progression of RP culminating in complete blindness means we begin in the region
where E7 is the stable solution (first stage of RP) and end up in the region where E2 is
the stable solution (complete blindness). Sample paths 1 and 2 in Figure 2 illustrate the
variability in RP and how identical changes in the parameters in two hypothetical different
patients (both with realistic parameter values) could yield different clinical manifestations
and even sub-types of RP[11, 8, 10]. In path 1 we track the progression by varying the
same Dm, Dn, and DT values of two hypothetical individuals with all other parameters
fixed at the same values except different Dc values (2.34×10
6 and 2.45×106, respectively
with both realistic) and observed very different manifestations of RP, E7 → E6 → E2
versus E7 → E2. In sample path 2 we see that while the observed sequence of RP stages
might be the same, the range of parameter values in each RP stage may vary drastically in
two patients[75, 76] even when only one parameter is different in their visual system. The
different ranges are indicative of the different options of available to halt the disease. This
finding is consistent with the established variability of RP between individuals [8, 76, 43].
Furthermore, this result opens the opportunity for multiple individual targeted therapies
to slow the progression of RP.
While we may be able to see all possible stages of RP in an appropriate parameter
region by varying at most two parameters, it is unlikely that this will be the norm phys-
iologically since these biological components are all interconnected and disturbances in
one can trickle down to others[10]. Thus Figure 3 shows how we could progress from
E7 to E4 to E2 in the most common rod-cone RP by varying three parameters, thereby
varying Dm, Dc, and DT . The relative size of the stability regions of E7 and E4 in this
space illustrate the various ways to remain in the RP stages corresponding to E7 or E4
both of which permit day/color vision. The progression of rod-cone RP illustrated in the
Sample Path (Figure 3) requires a decrease in the ratio of shedding to renewal of the
cones (Dc) together with a decrease in the necessary trophic factors (i.e., nutrient star-
vation) for the vision system of this hypothetical individual to fail to meet the metabolic
and functional needs of the photoreceptors (in the particular the cones). The changes in
shedding, renewal, and trophic factors required to move from one stage to another depend
on the differences of the relevant quantities Di−Dj , i 6= j. Counteracting these currently
inevitable trajectories of rod-cone RP in our model translate to changing Dc and such
changes correspond to new therapeutic approaches that bring back a balance between
shedding and renewal of the cone OS [73].
Currently there is no standard long-term treatment for RP, in part because the un-
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derstanding of RP is incomplete. There are many different theories for the physiological
processes triggering photoreceptor death and RP progression. Some of these causes, while
still having physiological value, can be contradictory or can explain only certain aspects of
RP progression, and/or only hold for the early stages of the disease. Research in this area
has improved the understanding of RP tremendously yet the possible mechanisms that
trigger its inevitable progression and offer potential long term therapies are still open ques-
tions. Our model provides a possible unified understanding to these two open questions.
Recent experimental research has focused on nutritional and drug therapy, the visual
transduction cascade, and the renewal and shedding of the POS [2, 77, 39, 43, 48, 78, 38].
For example, high dosage of vitamin A supplements have been utilized as a nutritional
therapy as it has been shown to cause an increase in the trophic factors of nutrients es-
sential for proper photoreceptor functioning[78] and our model illustrates this and similar
nutritional therapy in addition to growth factor delivery by an increase in DT . Likewise,
changes in the shedding and/or renewal of the POS, which have been proven to be critical
in the maintenance of healthy photoreceptors and are part of our main results, correspond
to changes in Dm, Dn, or Dc in our model depending on the specific type of photorecep-
tor that is affected. Gene therapy, which is currently being explored experimentally, in
our model corresponds to an impact on Dn directly by replacing mutant or errant genes
that affect normal rod shedding and/or renewal, and perhaps the others indirectly if their
renewal or shedding rates were affected through changes in Dn [47].
A promising new experimental approach to halt RP (and prevent total blindness)
corresponds to maintaining the stability of E4 (when only cones remain) in our model
and it involves the discovery of the RdCVF[45, 9, 39, 43, 47]. Mathematically and phys-
iologically, RdCVF is necessary in order for the cones’ viability and thus injections of
RdCVF offer a rescue effect on cone survivability and functionality in the absence of
rods[46]. However, other approaches to avoid complete blindness arise from mathemati-
cally analyzing the stability of E4 and the components that make it stable, which yield
the conditions Dc < Dn, DT > Dc, and Dc < Dm. While Dc is common in each and
could be addressed by changes in the cone shedding or renewal, the other three quantities
also must be considered to ensure that the cones-only steady state, E4, remains viable.
A myriad of experimental treatments could be investigated to address these conditions.
RP is the term used to describe a collection of inherited degenerative eye diseases,
which are not fully understood and for which reliable long term treatments still await[2,
12, 3, 11, 79, 40]. While the vast majority of mutations have been identified in the genes
that affect the rods, both rods and cones ultimately are affected[8, 7, 12, 39, 78, 11]. There
are numerous other degenerative eye diseases that are not termed RP but that follow
similar mechanisms of cell death triggered by mutations. Given the general structure
of our model examining photoreceptor interactions, we believe that this work will help
spur mathematical and experimental research in this area with the analogous conclusions
inferring multi-faceted approaches to slow the progression of many other degenerative
diseases.
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Appendix 1: Stability of Equilibrium Solutions
In order to examine the stability of the steady state solutions (3), we consider the linear
stability of each, together with the numerical observations (e.g., see Figures 2-3):
E1 = (0, 0, 0, 0)
We can easily calculate the eigenvalues λi = −(µn +m),−µm,−µc,Γ, which shows that
E1 is always a saddle point (unstable).
E2 = (0, 0, 0, DT )
This equilibrium is always physiologically relevant and denotes the trivial case in which
there are no rods (of either type) and no cones but only trophic factors. Physiologically
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this corresponds to total blindness in an individual. The eigenvalues are again readily
calculated as λi =
1
k
A3,
1
k
B1,
1
k
B2, −Γ. Any of the sub-types of RP could eventually lead
to this state.
E3 = (0,
B1
amβm
, 0, Dm)
The equilibrium E3 represents the long term existence of mutated rods and trophic factors
in the absence of cones and normal rods. E3 is physiologically relevant when B1 > 0,
which is exactly one of the conditions for E2 to be unstable. Thus as E3 ceases to
be physiologically relevant, it loses stability as E2 gains its stability in a transcritical
bifurcation, illustrated by the final stages of the sequences E7 → E6 → E3 → E2 and
E7 → E5 → E3 → E2. The eigenvalues of E3 are given by
A1
am
,
dmγC
∗
5
βm
, Dm
(
−k
2
±
1
2
√
k2 − 4B1/Dm
)
This will be stable for A1, C
∗
5
< 0 and B1 > 0, the latter also being the condition for E3
to be physiologically relevant.
E4 = (0, 0,
B2
acγ
, Dc)
E4 represents the situation where an individual only has day vision. It illustrates the
long term existence of the cones and trophic factors with both normal and mutated rods
having disappeared. It is a physiologically relevant solution when B2 > 0, which is exactly
one of the conditions for E2 to be unstable. The eigenvalues are given by
A2
ac
,
B3
ac
, Dc
(
−k
2
±
1
2
√
k2 − 4B2/Dc
)
.
This equilibrium point corresponds to a stage in the typical rod-cone RP in which both
types of rods die off before we observe the secondary wave of cone deaths (months and
even years after all rods have disappeared)[8]. Thus, we would expect this equilibrium
point to be a temporary state in an RP patient that physiologically ceases to exist when
the natural carrying capacity, k, of the trophic pool falls below a threshold value. This
will render the pool unable to sustain the demands required to maintain cone life and
functionality (i.e., nutrient starvation) when B2 becomes negative. The functionality of
the photoreceptor in this model is illustrated by a balance between natural renewal, ai,
and shedding, µi, i = n,m, c of the OS. Physiological experimental results have illus-
trated a lack of functionality by shorter OS and a larger diameter of the disc at the tip
of the OS[46]. Disturbances in the shedding or renewal process can lead to these mor-
phological changes. As a result of disturbances on this delicate balance the cones would
also eventually die off [73]. The stability of this equilibrium, E4, may give insight into
why the secondary wave of cone death may follow. Physiologically, we note that, e.g.,
Dc =
µc
ac
can increase with an increase in the shedding rate or a slowing of the renewal
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rate. As Dn, Dm, Dc, DT are all involved in the stability and/or existence of this equilib-
rium, experiments would need to keep in mind the potential interplay of these quantities
in determining exactly what processes may effect slight but crucial differences in these
quantities.
The eigenvalues of E5, E6, E7 are too cumbersome to write explicitly but we can still
gain insight by examining where each is physiologically relevant and in relation to the
stability of the other equilibria through bifurcations. We can, however, write the explicit
formulation for any λ = 0 bifurcations. Because our Result states that the bifurcations
describing the progression of RP occur through transcritical bifurcations, these expres-
sions will be useful.
E5 = (0,
B3
amdm
, C∗
5
, Dm)
E5 represents the long term existence of mutated rods, cones, and trophic factors with only
the normal rods having disappeared. This point is physiologically relevant when C∗
5
> 0
and B3 > 0. Remaining at this state is desirable for someone with RP, as presumably
the patient will still have color and day vision (due to the presence of the cones) and
some night vision (provided by the mutated rods). The eigenvalues are given by A1
am
and
a complicated cubic polynomial. Any λ = 0 bifurcations are given by
µmγA1B3C
∗
5
a2m
= 0.
Equilibrium point E5 corresponds to an earlier stage of the typical rod-cone RP in which
only the normal rods have died off and both cones and mutated rods still remain. We
would again expect this equilibrium point to physiologically represent a temporary state
before cones and mutated rods eventually die off as parameters in the system change.
E6 = (R
∗
n6, R
∗
m6, 0, Dn)
This equilibrium represents the death of all cones with the normal and mutated rods as
well as the trophic factors remaining. Besides depending on the renewal and shedding
rates, E6 also depends on the rate at which both types of rods remove trophic factors
from the trophic pool (βm, βn) and the production of the trophic factors itself (Γ). This
equilibrium can be interpreted as the first stage in the progression of reverse RP in which
an individual loses color and day vision. The eigenvalues are given by
C∗
7
γ(dnA1 + dmanm)
mβman + βnA1
and a complicated cubic polynomial. Any λ = 0 bifurcations are given by
(µn +m)γA1A3C
∗
7
a2n
= 0.
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In the paths involved in the various progression of RP, E6 loses stability in a transcritical
bifurcation with E3 in the sequence E7 → E6 → E3 → E2 or with E2 in the sequence
E7 → E6 → E2. Similarly, E6 gains stability through a transcritical bifurcation with E7.
Understanding the mechanisms (i.e., the parameters involved) in E7 → E6 is key as this
would give insight into circumventing any vision loss.
E7 = (R
∗
n7, R
∗
m7, C
∗
7
, Dn)
This equilibrium represents the only state in which all photoreceptors continue to survive.
It illustrates the first stage in RP where potentially there are no clinical manifestations of
RP. E7, in contrast to E6, besides depending on parameters governing production of the
trophic factors additionally depends on the ability (or lack thereof) of the cones to utilize
the RdCVF, quantified through dn and dm. The eigenvalues are given by a complicated
4th order polynomial. The λ = 0 bifurcations are given by
(µn +m)γA1B3C
∗
7
a2n
= 0.
This is the most desirable state for an individual with RP—both types of rods, the cones,
and the trophic factors are all still present in the system. Through an in depth analysis
of this steady state, we can examine how to prevent RP from running its normal course
by considering the conditions that will bring about qualitative changes that will render
this state unstable and move the system to another steady state previously mentioned.
Appendix 2: Parameter Estimation
In obtaining estimates on the parameters for (1), we begin with the healthy eye (non-
disease) version
R˙n = Rn(anT − µn)
C˙ = C(acT − µc + dnRn)
T˙ = T (Γ− kT − βnRn − γC). (4)
A few key experiments allow us to estimate five of these parameters. We then solve the
inverse problem with 9 data points from the aforementioned experiments to estimate the
remaining four parameters.
Shedding of photoreceptor outer segments
Numerous experiments, some in vivo and some in post-mortem patients, have estimated
the number of rod OS and cone OS that are shed per day. This number is typically given
in the number of days necessary to regenerate, i.e., all the OS to shed and be replaced by
new ones. Estimates depend on both the location of photoreceptor and the species under
consideration. If we consider only rhesus monkey and humans, we obtain an approximate
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shedding range (in days) of µn ∈
[
1
9
, 1
15
]
, µc ∈
[
1
8.5
, 1
15
]
. See [15, 22, 18, 80] for some
of these key experiments and results.
Rod-derived Cone Viability Factor
The ground breaking experiment of Leveillard et al. gives insight the approximate value
for the help the rods give the cones [45]. In their experiment in the rd1 mouse they showed
that the presence of RdCVF in a nutrient rich medium resulted in a 40% rescue effect.
The number of cones per mm2 after one week was 4200 compared with 3200 in their
cultured retinal explants. Assuming an exponential decay to represent the degradation in
the absence of RdCVF, we consider the equations
C˙ = −bC, C˙ = −bC + dnRnC (5)
to represent the cones in the absence and presence, respectively, of RdCVF. Solving and
eliminating b and assuming that we have a level of RdCVF remaining near constant levels
(where we let Rmax represent the number of rods that would be needed to generate this)
yields
dnRn
max ≈
ln
(
42
32
)
7 · 24
. (6)
Approximating Rmax as the average number of rods per mm2 (87.0× 103[15, 81]) gives a
lower bound. Knowing the equilibrium value (in terms of the various parameters) for R∗n
in the non-disease model gives another way of calculating dn as the value is constrained
once an, ac, µn, µc are known.
Inverse problem
An experiment on rhesus monkeys in which intact inner segments were transplanted into
the retina give us estimates on the renewal of rods and cones [26]. The specific data,
which also gave us the renewal estimates, states that the height of the OS discs on the
rods (given over mm2 area and as a fraction of the normal height) was .3, .33, and .44 at
the respective times of 7, 14, and 30 days after implant. In the cones, the same fractions
of the overall height of the OS were .31, .35, and .48. At the measurement of 150 days,
the height of the implanted photoreceptors was indistinguishable from that of the normal
photoreceptors. Assuming that the observations on this scale hold across the retina and
having known estimates of the numbers of rods and cones in the retina, we have 8 data
points that are the averaged over the 12 rhesus monkeys from the experiments. We also
know the number of RPE at steady state and this gives us a final value for the trophic
pool. Additionally, the same observations of [26] give observed values of the rod renewal.
The intervals given represent the range of the four best fit values (using Maximum
Likelihood Estimator [MLE]) utilizing the average total number of rods and cones in the
human eye as 91× 106 and 4.5× 106, respectively [15]. As there is approximately 1 RPE
cell for every 45 photoreceptors, we estimate the total RPE in the retina at 2.1 × 106.
Substitution of these quantities gives us the parameter values of our system; see Table 1.
The best fit graph is given in Figure 4.
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For the diseased model (1), we approximate βm = βn, dm = dn, am = an as first
approximations since we have not found data on any of those values. To estimate the
mutation rate, m, we estimated the total number of mutated rods based on the 14 year
progression of the disease (patient first noticed symptoms at age 10, and died at age
24, with the postmortem eye analyzed [82]. In doing so, we estimate a mutation rate of
m = 3.68× 10−7/day.
Appendix 3: Other Stable Solutions
As mentioned previously, we have observed stable periodic solutions for certain (unre-
alistic) parameter values. Analytically, we have shown that no non-degenerate Hopf
bifurcations (λ = iω, ω > 0) occur for any of the solutions E1, · · · , E7 for any choices
of parameter values (realistic or unrealistic). For Γ = 1.5 and the unrealistic values
an = 0.0028, ac = 0.00011, am = 0.0027, m = 0.01, µn = 0.4, µc = 0.15, µm = 0.4,
dn = 0.0002, dm = 0.00215, k = 0.0001, βn = 0.015, βm = 0.015, γ = 0.037, a stable
limit cycle exists in the full 4-dimensional space; see Figure 5. For the same parameter
values except for µc = 0.025, dm = 0.0055, k = 0.001, m = 0.1, we observe a stable limit
cycle in the 3-dimensional subspace Rn = 0; see Figure 6. Following these solutions with
MatCont has not yet allowed us to determine the bifurcation that gave rise to either of
these limit cycles.
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Table 1: Summary of parameters for non-diseased system taken from best 6 MLE results.
The equilibrium values for rods, cones, and trophic (RPE) are taken as 91×106, 4.5×106,
2.3× 106, respectively.
Variable Description Source
Γ ∈ [1.42, 1.56] Total inflow rate into the trophic factors MLE, [26]
k = 5× 10−7 Limiting capacity of trophic factors MLE, [26]
βn = 1.0× 10
−9 Constant per cell rate at which Rn withdraws T MLE, [26]
γ ∈ [4.55, 5.44]× 10−8 Constant per cell rate at which C withdraws T [26]
dn ∈ [0.90, 1.40]× 10
−11 Constant per cell rate at which Rn helps C [45, 26]
µn ∈ [
1
9.5
, 1
10
] OS shedding rate of Rn [15, 22]
µc ∈ [
1
9
, 1
9.5
] OS shedding rate of C [15, 22, 18]
an ∈ [4.3, 4.6]× 10
−8 Per cell renewal rod rate MLE, [26]
ac ∈ [4.5, 4.8]× 10
−8 Per cell cone renewal rate MLE,
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Figure 1: Flow-diagram of photoreceptor interactions affecting RP. Here we assume two
distinct classes of rod cells depending on whether or not they have had their functionality
compromised in any way as a result of the genetic mutation and distinguish them as
normal and mutated rods, Rn and Rm respectively. For these different types of rods,
the rate at which they draw from and utilize the trophic factors and their contribution
of Rod-derived Cone Viability Factor (RdCVF) may be different[45, 39, 43, 47]. In this
work, we do not attempt to distinguish between the causal mutations of RP. T represents
the RPE cells, which mediate the passage of growth factors, metabolites, ions, etc. to the
photoreceptors. Fractions of Rn, Rm, and C (cones) are interpreted as the outer segment
(OS) discs whereas fractions of T are viewed as the nutrients, etc. that are brought to the
photoreceptors via the RPE[28, 38].
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Figure 2: Possible paths to blindness in two hypothetical patients with cone-
rod RP. The planes illustrate the regions where various stages of RP are present in two
identical patients (i.e., the same Dn, γ, etc.) except for certain aspects of their cone
shedding to renewal ratio, Dc. Both Dc values (as well as all other parameter values) are
within the range of realistic values. The blue asterisk represents the parameter values from
the best fit (lowest MLE). The solid dark lines that separate the regions of parameter space
correspond to transcritical bifurcations of the Ei. Sample paths 1 and 2 in both patients
trace the same two sets of values for Dm and DT . Path 1 in patient 1 (Dc = 2.45 × 10
6
and is along Dm ≈ 2.45× 10
6) illustrates the path E7 (all photoreceptors present) → E6
(cones die off)→ E2 (all rods die off resulting in complete blindness) that corresponds to
a cone-rod RP path. The same sample path in patient 2 Dc = 2.34 × 10
6 is represented
by E7 → E2 and corresponds to simultaneous rod-cone death. (When varying only two
parameters there is a very narrow region of E6 stability, suggesting that C dies out first;
when varying three parameters, we can obtain E7 → E2.) The steady state solutions Ei
undergo transcritical bifurcations and change continuously throughout the plane so that
near a bifurcation set (represented by the bold lines/curves) two steady state solutions
are “close” in value. For example as we follow the path E7 → E2 the cones and both
types of rods decrease continuously as the parameter changes and just before crossing the
bifurcation line/curve into region E2 all photoreceptors are nearly zero, corresponding to
a patient being almost blind. Sample path 2 corresponds to the same progression in both
patients; E7 (all photoreceptors present) → E5 (normal rods die off ) → E3 (cones die
off)→ E2 (mutated rods die off giving total blindness) but the range of parameter values
in each stage (assuming identical reduction in trophic factors and in shedding to renewal
ratios) is different.
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Figure 3: Possible paths to blindness in a patient with rod-cone RP. In contrast
to Figure 2, the left picture fixes the ratio Dm and instead varies Dc and DT (with Dn
the same in both pictures and all parameter values within their realistic ranges). The
solid dark lines that separate the regions of parameter space correspond to transcritical
bifurcations of the Ei. A particular progress of the common rod-cone RP is illustrated
by the Sample Path. However, a more likely scenario is that three (or more) parameters
might change in order to give the common sequence E7 → E4 → E2. In the right picture,
we decrease the three ratios Dm, Dc, and DT to obtain the same clinically observed
sequence of stages of RP. (The asterisk is at the intersection point of each plane and the
numbers in the respective plane are the subscript of the stable steady state solution Ei.)
At any given point, it will be the case that multiple options exist to slow the progress of
RP by changing a combination of Dm, Dc, DT and thereby altering a given path in this
parameter space.
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Table 2: Summary of parameters for system (1).
Variable Description Units
Γ Total inflow rate into the trophic factors 1/t
k Limiting capacity of trophic factors 1/T t
βn Constant per cell rate at which Rn withdraws T 1/Rnt
βm Constant per cell rate at which Rm withdraws T 1/Rmt
γ Constant per cell rate at which C withdraws T 1/Ct
dn Constant per cell rate at which Rn helps C 1/Ct
dm Constant per cell rate at which Rm helps C 1/Ct
q1 Per cell conversion factor Rn/T
q2 Per cell conversion factor Rm/T
q3 Per cell conversion factor C/T
µn Per cell death rate of Rn 1/t
µm Per cell death rate of Rn 1/t
µc Per cell death rate of C 1/t
m Per cell mutation rate of Rn 1/t
an Per cell renewal rate βnq1 1/T t
am Per cell renewal rate βmq2 1/T t
ac Per cell renewal rate γq1 1/T t
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Figure 4: Best least squares fit (MLE) for inverse problem using data from
[26]. The quantities in the trophic equation are unknown and all but one of the other
parameters have a range of values from the experimental literature. The five circles in
each graph are the data points at 7, 14, 30, 150, and 250 days, with only the last two
points known in the RPE. The specific values used are an = 4.5×10
−8, ac = 4.7×10
−8,Γ =
1.48, k = 5×10−7, γ = 4.88×10−8, µn = 1/9.5, µc = 1/9, βn = 1×10
−9, dn = 1.29×10
−11.
The assumed steady state values of R∗n ≈ 91× 10
6, C∗ ≈ 4.5× 106, T ∗ ≈ 2.3× 106 for the
normal rod OS, cones OS, and RPE, respectively.
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Table 3: Steady states and corresponding stages of RP. Each of the steady state solutions
represents a (stable) stage of RP that can be attained for some set of parameter values
with the exception of E1, which is never stable. Many different sub-types of RP can be
identified depending on the stable equilibrium that occur as parameters are changed.
Steady State Stage of RP RP sub-type Physiological Description
E7 Early, Mid-late All types Normal rods, mutated rods,
cones, trophic factors all exist
E6 Mid-late Cone-Rod Cones have died off; both types
of rods, trophic factors remain
E5 Mid Rod-Cone No normal rods; mutated rods,
cones, trophic factors remain
E4 Mid-late Rod-Cone all rods have died; cones,
trophic factors remain
E3 Mid-late Cone-Rod Cones and normal rods have died;
mutated rods and trophic factors remain
E2 Late All types Complete blindness with no rods or
cones; trophic factors remain
E1 NA NA No rods, cones, or trophic factors
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Figure 5: Stable limit cycle observed in the full 4-dimensional space. The
parameter values at which this stable limit cycle exists are Γ = 1.5, an = 0.0028, ac =
0.00011, am = 0.0027, m = 0.01, µn = 0.4, µc = 0.15, µm = 0.4, dn = 0.0002, dm =
0.00215, k = 0.0001, βn = 0.015, βm = 0.015, γ = 0.037. Note that the axes are not in
millions but are instead the number of OS and RPE (original definition).
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Figure 6: Stable limit cycle observed in the 3-dimensional subspace, Rn = 0.
The parameter values at which this stable limit cycle exists are Γ = 1.5, an = 0.0028,
ac = 0.00011, am = 0.0027, m = 0.1, µn = 0.4, µc = 0.025, µm = 0.4, dn = 0.0002,
dm = 0.0055, k = 0.001, βn = 0.015, βm = 0.015, γ = 0.037. Note that the axes are not
in millions but are instead the number of OS and RPE (original definition).
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